Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: June 27, 2026
Closing price before research date: $10.95
Current price: $13.38

Venture Global, Inc. (NYSE: VG) — Best Builder, Worst Counterparty: A Levered Option on LNG It Still Has to Finish

Independent fundamental research. Report date: 2026-06-27.

This article carries no buy/sell recommendation and no price target in its analytical body. The single, deliberate exception is the Author’s Take block immediately below, which is fenced off as a subjective view.


⚡ Author’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice. Everything below it is position-free analysis.

Verdict: AVOID here as an investment / NOT a short / speculative-accumulate only on deep weakness (sub-~$9). Conviction: MEDIUM-LOW. This is not a stock to own at ~$10.95 if you want to sleep at night, and not a stock to short if you want to keep your shirt — 87% of the float is already short, the founders are buying, and the equity is a thin, violently-levered residual sitting behind ~$35B of net debt, ~$3.5B of minority interest, and a potentially-uncapped $3.7–6.0B BP arbitration tail. The honest framing is a levered option on completion, not a cash-flow business you can underwrite today.

What the market is pricing roughly correctly: that VG’s trailing EBITDA (~$6.2B TTM) is a commissioning-cargo mirage — high-margin spot LNG sold before commercial operations into the 2022–23 and 2025–26 price spikes — and that the steady-state contracted economics (47–52 mtpa of 20-year, fixed-fee take-or-pay SPAs at ~$2.25–3.25/MMBtu) are a lower-margin annuity. On normalized contracted EBITDA the stock is ~13x EV/EBITDA, not the 10.6x headline — i.e., it is not cheap; the discount to Cheniere is a rational risk discount, not a bargain. What the market may be under-weighting on the upside: this management genuinely builds faster and (historically) cheaper than anyone in LNG, the contracted book is real and growing, and a successful Plaquemines COD + CP2 completion converts option value into annuity value. What it may be under-weighting on the downside: the company is at open legal war with the Tier-1 majors who fund LNG FIDs, having delayed Calcasieu’s commercial start ~3 years to pocket the spot windfall — and it is structurally set up to do the same thing at Plaquemines. That is the rare case where the “moat” (modular low-cost building) and the “sin” (stiffing your customers) are the same act, and the sin is the one that compounds.

Framing: a broken-IPO, falling-knife-that-bounced — capitulated to $5.72 on the October-2025 BP loss, ripped +200% on the Repsol/Edison wins, then rolled back −38% as the glut, CP2 execution and the BP damages phase all stayed unresolved. It trades as a 77%-vol oil-price-and-credit-beta commodity bet (the factor model mis-clusters it with E&P names; Cheniere isn’t even in its peer set), not the utility-like infrastructure annuity the bulls model. Conviction MED-LOW. Single bullish flip: Plaquemines reaches COD on schedule (Q4-2026) and converts to contracted without a new customer arbitration, while BP settles near VG’s $595M cap. Single bearish flip: the BP damages award lands in the billions uncapped, or a Plaquemines foundation customer files the second grievance. Directional zone: fair value is a wide ~$8–20 with a fat left tail toward zero; I’d only buy the completion option below ~$9, and I would not chase it above the mid-teens. Tag: “The cheapest builder in LNG, at war with the customers who fund it.”


📈 Stock Price Action — Five-Year Event Map

Text-only price history. VG has traded for only ~17 months (IPO 2025-01-24), so this is the full public history, not five years. Price moves are FACT; attributed causes are INTERPRETATION. No recommendation, no price target.

Arc. VG priced its IPO at $25 on 2025-01-24 (cut from a $40–46 marketing range), opened around $24, and printed its all-time intraday high of ~$25.50 on day one — it has never traded higher. From there it slid to an all-time intraday low of $5.72 on 2025-12-16, rebounded to a 2026 high of ~$17.62 (2026-03-24), and now sits at $10.95 (2026-06-26)~57% below its day-one high, inside a 52-week range of roughly $5.72–$18.06, and below both its 50-day (~$12.33) and 200-day (~$12.02) EMAs. A broken-IPO round-trip: down 77%, then roughly half-way back, then fading again.

# Period Approx. move Price (~from → to) Primary driver(s) Fact / Interp
1 Jan 24–28 '25 ~−17% $24.0 → $19.9 IPO priced $25 (cut from $40–46) and faded on day one — a broken IPO from the open F price / I cause
2 Feb–Apr '25 ~−65% $20.4 → $8.4 FY24 print + first wave of Calcasieu COD-delay arbitration headlines (Shell/BP/Edison/Repsol) F / I
3 May–Jun '25 ~+86% $8.4 → $15.6 CP2 progress, DOE non-FTA permitting tailwind (Trump), short-covering off a washed-out base F / I
4 Jul–Sep '25 range ~$13–15 Plaquemines ramp vs. unresolved arbitration; CP2 Phase 1 FID + $15.1B financing (Jul-2025) F / I
5 Oct–Dec '25 ~−60% $14.2 → $5.72 BP partial final award (Oct-8-2025) — VG found in breach, BP seeking $3.7–6.0B — plus glut fear F / I
6 Jan–Mar '26 ~+207% $5.72 → $17.62 VG won Repsol (Jan), settled Edison; strong Q4’25/Q1’26 prints; relief rally + short-squeeze F / I
7 Apr–Jun '26 ~−38% $17.62 → $10.95 Bounce exhaustion; glut/embedded-expectations reassert; Iran-war/Hormuz energy spike then faded F / I

Cycle narrative. (1–2) The IPO was a marked-down deal that never found footing; the first prints and the arbitration drumbeat took it down two-thirds in a quarter. (3–4) A commodity/permitting bounce and the CP2 FID stabilized it mid-year. (5) The defining capitulation was the BP partial award — the first time a tribunal ruled VG breached its duty to declare commercial operations — which, layered on glut fear, drove the stock to its all-time low. (6) A +200% melt-up followed the Repsol win and Edison settlement plus a record short base. (7) The most recent leg gave back ~38% as the Iran-war energy spike reversed and the market re-confronted the unresolved trio of BP damages, Plaquemines COD timing, and the 2026–28 supply glut. The tape has been trading VG as a high-beta levered commodity instrument, not as a contracted-infrastructure annuity.


1. Executive Summary

Venture Global is the second-largest US LNG exporter by capacity-in-motion and the fastest-growing LNG developer in the world. It owns and operates Calcasieu Pass (10 MTPA, commercial operations declared April 2025), is commissioning Plaquemines (~27 MTPA peak, first cargo December 2024, COD guided Q4-2026/mid-2027), reached final investment decision on CP2 (~28 MTPA) in mid-2025 with a record ~$20.7B of project financing across two phases, and has CP3 (~30 MTPA), Delta, and a filed +31 MTPA Plaquemines brownfield expansion behind that. Its calling card is a “design-one, build-many” modular liquefaction architecture — electric-drive trains prefabricated in Italy by Baker Hughes and shipped fully assembled — that historically delivered the lowest capex-per-tonne in the industry and the fastest schedule.

The investment problem is fourfold, and the four problems compound rather than offset.

First, the earnings are a commissioning mirage. VG’s blowout trailing numbers come overwhelmingly from selling commissioning cargoes at spot prices during the multi-year window before a project declares commercial operations — exactly what it did at Calcasieu (~250 cargoes into the 2022–23 European spike) and is doing now at Plaquemines. Gross margin has fallen from 55.9% (Q1’25) to 34.0% (Q1’26) as contracted, fixed-fee volumes displace the spot windfall. The steady-state business is a 20-year, take-or-pay liquefaction-fee annuity at ~$2.25–3.25/MMBtu — stable, but far lower-margin than the trailing print implies. Normalize EBITDA down before valuing anything.

Second, the balance sheet is junk-levered and still building. Net debt is ~$35B against reported EBITDA of ~$6.2B (~5.6x, and higher on normalized EBITDA). HoldCo notes carry 8–10% coupons, there is a $3.0B 9.5% perpetual preferred, and the company has burned negative free cash flow every year (−$11.6B in 2024, −$6.8B in 2025) on ~$13B/year of capex. It will not generate positive FCF until CP2/CP3 complete around 2028+.

Third, the company is at legal war with its own customers. Because VG delayed Calcasieu’s commercial start ~3 years to capture spot, foundation SPA customers — Shell, BP, Repsol, Edison and others — filed arbitrations seeking billions. VG has won some (Shell, Repsol) and settled others (Edison), but lost the liability phase to BP in October 2025; BP seeks $3.7B to over $6.0B, and VG’s own 10-K concedes its $595M aggregate liability cap likely will not apply to BP. Three more Calcasieu arbitrations are pending, with awards expected in 2026. Plaquemines is structurally set up to repeat the pattern.

Fourth, it is the most glut-exposed major in a glutting industry. The 2025–2030 global LNG supply wave (~+200 MTPA, led by Qatar’s North Field and a doubling of US capacity) is the largest in history and is already compressing the Henry-Hub-to-destination spread that VG monetizes. VG — spot-heavy and still pre-COD on most of its capacity — is the most exposed US name to that compression.

Against all that: the contracted book is real (47–52 MTPA executed, ~$299.5B remaining performance obligation per the 10-K), the build execution is genuinely best-in-class, the founders are buying their own stock in the open market, and the permitting environment under the current administration is maximally favorable. At ~$65.5B EV, the equity prices Calcasieu + Plaquemines completing and performing, with CP2/CP3 as partly-unpaid optionality — a defensible structure with an enormous variance band (a near-equity-wipe bear, a ~$18–22 base, a ~$35–40 bull). This is a special-situation, levered completion option, not a quality compounder. The body that follows is position-free; the judgment is in the Author’s Take above.


2. Business Overview

What VG does. Venture Global builds and operates LNG liquefaction-and-export terminals on the US Gulf Coast (Louisiana). It buys domestic natural gas (linked to Henry Hub), liquefies it by chilling it to ~−260°F, loads it onto LNG tankers, and sells it to global buyers in Europe and Asia. It also owns associated pipeline (the Calcasieu, TransCameron, and CP Express pipelines) and a fleet of chartered/owned LNG carriers, and undertakes some regasification activity. [FACT — 10-K FY2025; company profile]

How it makes money — a merchant/tolling hybrid, and the distinction is the whole story. VG runs two revenue engines:

  1. Commissioning / spot sales. During the multi-year pre-COD “commissioning” phase, each newly-built train produces LNG that VG sells at prevailing spot prices under short-term commissioning-sales agreements. This is the windfall engine. Calcasieu commissioned from January 2022; Plaquemines has been commissioning since December 2024. [FACT — 10-K Note 4]
  2. Post-COD contracted SPAs. Once a project declares its Commercial Operations Date (COD), output flows to 20-year, fixed-price, take-or-pay Sale and Purchase Agreements. The customer pays a fixed liquefaction fee even if it cancels the cargo, plus a variable commodity fee set at 115% × Henry Hub (for FOB sales); DES sales price off TTF/JKM. [FACT — 10-K Note 4]

The contracted book at FY2025 year-end was 47.0 MTPA executed (since grown past 52 MTPA with new signings), ~96% under the 20-year take-or-pay structure, with a remaining performance obligation of ~$299.5B over a weighted-average 19.6 years. [FACT — 10-K Note 4] That backlog figure embeds a forecast Henry Hub and excludes spot upside; treat it as an order-of-magnitude annuity, not a precise NPV.

Revenue mix and the commissioning mechanism. The defining operational fact: Calcasieu produced first LNG in January 2022 but declared COD only on April 15, 2025 — roughly three years late (VG attributes the delay to force-majeure-extended commissioning). During that extended window VG sold the output at spot into the 2022–23 spike (TTF peaked near $89/MMBtu) rather than delivering to its foundation SPA customers. That single decision is the source of both the extraordinary 2022–24 reported returns and the arbitration wave (see the Competitive Position and Changes sections). Plaquemines is now repeating the pattern — commissioning at spot since early 2025, with COD not yet declared and Q4’25 commissioning realizations of ~$6.20/MMBtu versus Calcasieu’s post-COD ~$2.10/MMBtu. [FACT — transcripts; 10-K]

Customer base and concentration. Counterparties are global utilities, majors and traders: Shell, BP, Edison, Repsol, Galp, PGNiG/Orlen, Sinopec, CNOOC, plus newer signings (Naturgy, Mitsui, Tokyo Gas, Hanwha, Trafigura, Vitol, TotalEnergies, EnBW, ExxonMobil/Atlantic-SEE). Concentration is high: the top three customers were ~50% of 2025 revenue (A ~23%, B ~14%, C ~13%). [FACT — 10-K Note 4]

Recurring vs. non-recurring. Post-COD SPA revenue is genuinely recurring and contracted. But a meaningful share of current revenue is non-recurring commissioning spot plus excess-capacity volumes sold at spot — which is precisely the high-margin slice that normalizes away as projects reach commercial operations. This is the single most important thing to understand about the income statement.

Verdict. A capital-intensive, two-engine LNG export business whose durable engine is a contracted fixed-fee annuity and whose trailing economics are dominated by a non-repeatable commissioning windfall. The business is real and growing; the reported profitability is not the steady state.


3. Industry Dynamics

Structure. Global LNG is a capital-intensive commodity midstream industry: gas is liquefied, shipped, and regasified, with the producer’s economics set by the spread between feed-gas cost and the delivered price in Europe (TTF) or Asia (JKM). The US has become the world’s largest exporter — roughly 102 MTPA / ~18.3 Bcf/d in early 2026 — and US export capacity is set to roughly double by 2030–31 as Golden Pass (first LNG March 2026), Rio Grande, Port Arthur, and the Cheniere/VG expansions ramp. [FACT — EIA, 2026]

The defining fact is the 2025–2030 supply glut. The industry is digesting the largest supply wave in its history — roughly +200 MTPA of post-FID capacity, pushing global liquefaction toward ~740 MTPA by 2030 (+~40%). Qatar’s North Field alone adds ~49–65 MTPA. Rystad has modeled +193 MTPA of supply against only ~+144 MTPA of incremental Asian demand over 2025–30; the IEA sees on the order of a 15% capacity surplus by 2030. The arbitrage VG monetizes — Henry Hub near ~$3 versus TTF/JKM at ~$17–20/MMBtu in the spike years — is already compressing: the TTF–HH spread narrowed to ~$4–6 by late 2025 from ~$8–12 in 1H25, and Argus has noted that ~$3 liquefaction-fee contracts could exceed delivered NW-Europe prices by summer 2027. [FACT — Rystad, IEA, Argus, 2025–26]

Demand is real but lags the wave. Structural demand drivers are genuine — Shell projects global LNG demand rising from ~422 MTPA toward 650–710 MTPA by 2040; the EU’s January-2026 law phasing out Russian gas; coal-to-gas switching; and AI-datacenter power load. But on the 2026–2028 horizon the supply additions arrive faster than demand, which is the window that matters for VG’s pre-COD economics and its next round of SPA pricing.

Regulation and the permitting tailwind. US LNG export requires FERC authorization for the facility and DOE authorization to export to non-FTA countries. The Biden-era DOE “pause” on new non-FTA approvals ended in January 2025, and the current administration has been maximally favorable — CP2 secured its approvals, and FERC procedural relief has accelerated timelines. This is a genuine tailwind for VG’s growth pipeline — but it adds to the very glut that compresses margins, and it is reversible with a change of administration. [FACT — DOE/FERC, 2025–26; INTERPRETATION on reversibility]

Capital-cycle read (Marathon lens). This is a textbook late-cycle overbuild. The 2022–23 price spike generated extraordinary returns that pulled a flood of FIDs — the US has accounted for roughly 60% of global FIDs since 2019 — and capacity additions peak around 2028 just as the spike-era margins mean-revert. High returns attracted capital; capital is now arriving in force; margins will compress. VG, being the most spot-exposed and still-building major, sits at the most cyclically-exposed point of that curve.

Verdict: a structurally bad (commodity, price-taking) industry entering a multi-year margin-compressing glut, attractive only for the lowest-cost, fully-contracted operators. The contracted, tolling-style model (Cheniere) is defensible through the cycle; the spot-heavy, still-building model (VG) is the most exposed.


4. Competitive Position

The moat question — name the mechanism or its absence. In Greenwald’s taxonomy, the only credible candidate for VG is a supply-side cost advantage: lower capex-per-tonne and faster schedule from modular, factory-fabricated trains. On the legacy assets, that advantage is real and measurable — Calcasieu was built at roughly $580/tonne and Plaquemines at ~$780–880/tonne, below NextDecade’s Rio Grande at ~$1,022/tonne. [FACT/INTERPRETATION — filings, industry estimates]

But the cost moat is converging away on new builds. CP2’s total project cost has been guided up to $32.5–33.5B for ~28 MTPA ≈ $1,160–1,200/tonne — at or above peer levels — on tariffs and design changes. [FACT — 10-K] The implication is important: the vaunted “lowest-cost builder” edge rests on the first two projects (built in a cheaper cost environment and partly self-funded by the spot windfall) and largely disappears on CP2/CP3/Delta. A cost advantage that does not persist into the next vintage of projects is not a durable moat; it is a first-mover timing advantage.

No pricing power. VG is a price-taker. Commissioning and excess-capacity revenue is pure spot commodity exposure. Even post-COD, a meaningful component of realized economics stays spot-linked, and the 20-year SPA liquefaction fee was set competitively against Cheniere and the other developers — it delivers cash-flow stability, not pricing power. There is no mechanism by which VG can raise price to a captive customer base.

Reputation as a quantified moat-negative — the distinctive feature of this name. VG’s relationships with the Tier-1 majors who anchor LNG FIDs are impaired by its own conduct. Four Calcasieu customers went to arbitration over the three-year COD delay; BP won the liability phase in October 2025, with a tribunal finding that VG breached its duty to declare COD as a “Reasonable and Prudent Operator.” This is the rare situation where the source of the historical windfall (selling commissioning cargoes at spot rather than delivering them) is also the source of a multi-billion-dollar legal tail and a lasting trust deficit with the exact counterparties VG needs for future SPAs and financings. If the “moat” (build cheap, commission long, sell spot) were removed, the financial outcome that would deteriorate is essentially the one-time commissioning windfall — which is non-repeatable and was itself the cause of the lawsuits. By the playbook’s own test, that is not a moat; it is a non-recurring trade dressed up as a competitive advantage.

Direct comparison vs. Cheniere (LNG). The contrast is stark and instructive:

Dimension Venture Global (VG) Cheniere (LNG)
Contract coverage ~96% of executed SPAs take-or-pay, but much capacity still pre-COD/spot ~95%+ contracted, fully operational
Credit ~BB/high-yield; 8–10% HoldCo coupons Investment-grade (~BBB-)
Net debt ~$35B, still building ~$23B against operating cash flows
Counterparty reputation Impaired — in arbitration with majors Clean, trusted tolling counterparty
Earnings quality Commissioning-spot inflated Stable utility-like tolling fees
Stage Building (CP2/CP3 ahead) Built, harvesting + measured expansion

Cheniere trades at ~15x EV/EBITDA, VG at ~10.6x trailing (~13x normalized) — the discount is a rational risk discount for leverage, spot-dependence, reputation and execution, not a valuation bargain (see Valuation).

Verdict: not a durable moat. A commodity LNG developer with a real-but-eroding early-mover capex advantage, no pricing power, extreme customer concentration, severe counterparty-reputation impairment, and a material uncapped litigation tail — entering a global glut. Execution, reputation, and glut risk dominate the thesis.


5. Growth History and Forward Opportunities

Historical growth. VG’s revenue arc is dominated by commissioning timing, not underlying demand: ~$6.4B (2022) → ~$7.9B (2023) → ~$4.97B (2024, as Calcasieu’s commissioning windfall faded pre-COD) → $13,769M (2025) as Plaquemines commissioning cargoes ramped, → $15,474M TTM through Q1’26. The quarterly ramp (Q1’25 $2,894M → Q4’25 $4,445M → Q1’26 $4,599M) is the Plaquemines spot windfall building, not a contracted run-rate. The same applies to EBITDA ($3.7B/$5.1B/$2.1B/$6.1B across 2022–25) — these are spot-driven swings, not a smooth growth curve.

Forward opportunities — the volume pipeline is enormous, and that is genuinely the bull case. VG’s contracted nameplate path is, on paper, one of the largest growth stories in energy:

  • Calcasieu Pass — 10 MTPA, operating (COD April 2025).
  • Plaquemines — ~27 MTPA peak, commissioning; Phase 1 COD guided Q4-2026, Phase 2 mid-2027.
  • CP2 — ~28 MTPA; Phase 1 FID Jul-2025 ($15.1B financing), Phase 2 FID early-2026 ($8.6B), first LNG guided H2-2027.
  • CP3 — ~30 MTPA, planned.
  • Plaquemines brownfield expansion+31 MTPA filed with FERC/DOE November 2025, nearly doubling that site’s peak output.
  • Delta — additional planned capacity.

If even Calcasieu + Plaquemines + CP2 reach commercial operations and perform, contracted volume more than doubles from today’s operating base — which is the engine of the base/bull valuation cases. The SPA book has grown from 47.0 MTPA (FY25) past 52 MTPA with a string of 2025–26 signings (Naturgy, Mitsui, Tokyo Gas, Hanwha — its first South Korean deal, Trafigura, Vitol, TotalEnergies, EnBW +0.82 MTPA in June-2026, and an ExxonMobil/Atlantic-SEE +1 MTPA 20-year deal in June-2026), demonstrating that — arbitration notwithstanding — VG is still signing offtake. [FACT — 8-Ks, news, 2025–26]

Quality of growth — low, despite the magnitude. This is debt-funded, commodity-exposed volume growth, not high-return organic compounding. Each incremental MTPA earns a competitively-set fixed fee, requires ~$1.1–1.2B of capex per the latest vintage, and arrives into a glutting market that pressures both spot upside and future SPA pricing. The growth is large but low-quality by the playbook’s standard: it is throughput growth bought with leverage, not economic-profit growth.

Verdict: high-magnitude, low-quality growth. The volume runway is real and is the legitimate core of the bull case, but it is funded by junk-rated debt into a compressing-margin industry, and most of the value is in trains that are not yet operating.


6. Financial Quality

The margin tell is unambiguous — and it is the crux of the entire memo. Gross margin has collapsed across five quarters even as revenue ramped: Q1’25 55.9% → Q2 45.6% → Q3 51.8% → Q4 48.4% → Q1’26 34.0%. EBITDA margin has held in the low-40s only because of scale; the gross line shows the underlying economics deflating as high-margin commissioning spot cargoes give way to contracted SPA volumes (fixed liquefaction fee + pass-through commodity cost) and rising feed-gas costs. The contracted steady state is structurally lower-margin than the trailing print. [FACT — ROIC/filings]

Depreciation is a loaded spring. Gross PP&E is $52.5B (Q1’26) against accumulated depreciation of only $1.99B — the asset base is barely depreciated because most capacity only recently reached COD (Calcasieu, April 2025) or is still commissioning (Plaquemines). FY25 D&A already rose ~$597M as Plaquemines trains were placed in service, and this accelerates for years, weighing on GAAP margins as the spot windfall simultaneously fades. The two forces — falling realized margin and rising depreciation — both cut the same way.

Quality of earnings is poor; reported NI is commodity-mark-distorted. Net income swings on non-operating “change in fair value of forward natural gas supply contracts”: Q4’24 carried a −$704M other-non-op line (yet pretax was +$1,238M); Q1–Q3’25 carried +$192M/+$175M/+$289M; Q1’26 carried +$415M of non-op income. FY25 NI of $2,733M includes $638M of deferred tax and ~$2.0B of “other non-cash” adjustments per the cash-flow statement. The TTM EPS of ~$1.01 is therefore inflated by both commissioning spot cargoes and favorable marks — discard it as a valuation anchor and lean on EV/EBITDA (normalized), P/B, and the project NAV. [FACT — filings]

Capital intensity is extreme and FCF is deeply negative. Capex was $13.7B (2024) and $13.4B (2025); operating cash flow was $6.57B in 2025, leaving free cash flow of −$11.6B (2024) and −$6.8B (2025) (after −$0.9B/−$3.5B in 2022/2023). The business will not generate positive FCF until CP2/CP3 complete (~2028+). This is the financial signature of a developer mid-build, not an operator harvesting cash.

Returns on capital are distorted and, normalized, unimpressive. Aggregated data shows ROIC of 54% (2022) / 22.7% (2023) / 4.7% (2024) / 10.3% (2025) — wildly distorted by commissioning-cargo timing in the numerator and a huge in-construction CWIP base in the denominator. The “true” return on a contracted train is the fixed liquefaction-fee margin on ~$1.1–1.2B/MTPA of capex; management claims >30% project ROIC on CP2, but with CP2 capex now at peer-level $/tonne and SPA fees competitively set into a glut, that claim deserves skepticism until demonstrated. There is no clean, sustained ROIC > WACC track record yet — the asset base is too young and too spot-distorted to prove one.

Verdict: economics are a stable contracted annuity once built, but current profitability materially overstates the steady state. Commissioning-spot revenue, favorable gas marks, and minimal depreciation flatter the run-rate; the 56%→34% gross-margin slide in five quarters is the real signal. Normalize EBITDA down before valuing.


7. Capital Allocation

The IPO did not de-lever. The January-2025 IPO priced at $25 (cut from a $40–46 range), sold ~70M Class A shares, and raised ~$1.7B net — used for general corporate and project funding, not debt reduction. For a company carrying ~$35B of net debt, the equity raise was a rounding error against the capital program; this is a debt-funded build with a thin equity sliver on top.

A serial-FID growth machine — the Marathon red flag. The capital-allocation pattern is relentless asset growth: Calcasieu (COD April 2025) → Plaquemines (commissioning) → CP2 FID Jul-2025 ($15.1B) + Phase 2 early-2026 ($8.6B) → CP3 planned → Plaquemines +31 MTPA expansion filed Nov-2025 → Delta. It is a debt-funded supply build, partly self-funded by spot windfalls — the textbook high-returns-attract-capital dynamic that the capital-cycle framework warns mean-reverts. Management is explicit in transcripts that it will reinvest everything (“bolt-ons are the highest returns in LNG”), with dividends/buybacks only “as CP2 cash flows materialize.”

Dividends and buybacks are token. The common dividend was ~$0.03/share for all of 2025. The $465M of “dividends paid” in the cash-flow statement is dominated by the $3.0B 9.5% VGLNG Series A perpetual preferred (~$270M/yr) plus subsidiary/NCI distributions — not common. SBC is modest (~$46M FY25). There is essentially no capital return to common holders, by design, for years.

Balance-sheet architecture — non-recourse, SPA-backed, but expensive. The ~$37B of debt is overwhelmingly project-level and non-recourse, financed per SPV:

  • VGLNG (HoldCo): senior secured notes — $2.25B 8.125% '28, $2.25B 8.375% '31, $3.0B 9.50% '29, $2.0B 9.875% '32, $1.5B 7.00% '30 (8–10% coupons = junk-grade pricing) — plus a $2.0B revolver (Nov-2025) and the $3.0B 9.0% Series A perpetual preferred.
  • Calcasieu (VGCP): the original $5.8B construction term loan was refinanced into ~$5.0B of notes (3.875–6.25%, 2029–2033); the residual term loan that matured August-2026 has since been fully repaid via a $750M note issuance, neutralizing the nearest refinancing wall, and VG redeemed the $1.6B Stonepeak preferred (saving ~$100M/yr) in a Q2-2026 capital-structure simplification. [FACT — 8-Ks, transcripts]
  • Plaquemines (VGPL): ~$12.9B construction term loan + $2.1B working capital, being termed out via $2.5B/$4.0B/$3.0B note issues (6.1–7.75%).
  • CP2: ~$20.7B across the two FIDs (2028/2032 maturities).
  • Blackfin/CP Express pipeline: ~$1.6B (Sep-2025).

The structure is the standard LNG-developer model and is sustainable so long as projects complete on schedule and SPA counterparties perform — but the coupons are high-yield, the construction balances are large and partly floating, the interest burden is ~$1.8B/year and rising, and the current ratio is below 1.0 (0.87x). [FACT — filings]

Insider behavior — the genuinely two-sided finding (and a correction to the lazy read). The EDGAR Form 4/Form 144 “flood” (51 Form 4s, 34 Form 144s since IPO) is not founders dumping. It is junior officers doing cashless exercise-and-sell of options struck at ~$0.79 (code M exercise → same-day code S sale) — e.g., the General Counsel ~1.11M shares at ~$11.5–11.9 (Jun-2026), the CCO 500K at $13.69 (Sep-2025), an SVP ~1.0M at ~$7.80–8.01 (Nov-2025). Routine post-IPO monetization off a near-zero basis. By contrast, the founders are net open-market BUYERS: Sabel and Pender (via Venture Global Partners II LLC) have made repeated code-P purchases — Sabel 250,000 @ $9.37 (Mar-10-25), 234,500 @ $10.53 (Mar-14-25), 1,226 @ $13.04 (Jun-12-26), with Pender mirroring — buying at or below the IPO price. That is a mildly bullish skin-in-the-game signal and should not be mischaracterized as insider distribution.

Governance and incentives — the weak spot. The founders hold 100% of Class B shares (1.97B shares, 10 votes each) = ~79% of economics and ~97.5% of total voting power. Outside Class A holders have essentially no governance check. Worse, executive pay is anchored on project-milestone bonuses (FID, first cargo/LPS, COD) and EBITDA growth — the proxy celebrates “+198% EBITDA” — with no ROIC, no return-on-capital, and no per-share metric anywhere in the plan. CEO Sabel’s 2025 total comp was ~$39.1M. The incentive design explicitly rewards FID velocity, throughput and EBITDA scale — i.e., it pays for exactly the debt-funded over-build the capital-cycle lens flags as the central risk.

Verdict: mixed, leaning negative on alignment-of-design. Founders are aligned by ownership (super-voting control plus open-market buying) and the SPA-backed financing model is coherent. But capital allocation is a debt-fuelled serial-FID growth engine that did not de-lever at IPO, returns to common holders are symbolic, comp rewards growth/throughput with zero capital-efficiency or per-share metric, and ~97.5% founder voting control leaves outside holders no check. Aligned by skin-in-the-game; misaligned by incentive design and governance.


8. Changes and Headwinds — Last Two Years

The last two years are the company’s entire public life, and they have been eventful in both directions.

Strengthening developments. (1) IPO (January 2025) — albeit a marked-down deal. (2) Calcasieu COD (April 2025) — the first project reached commercial operations and began contracted deliveries, which after a multi-year delay finally started the SPA clock. (3) CP2 FID + record financing — Phase 1 ($15.1B, July 2025) and Phase 2 ($8.6B, early 2026) for a combined ~$20.7B, described as the largest standalone project financing ever. (4) An SPA blitz since re-entering the market in April 2025 — Naturgy, Mitsui, Tokyo Gas, Hanwha (first South Korea), Trafigura, an upsized Vitol deal (to 1.7 MTPA), TotalEnergies (0.85 MTPA), EnBW (+0.82 MTPA, June 2026), and ExxonMobil/Atlantic-SEE (+1 MTPA, 20-year, June 2026) — growing the book past 52 MTPA. (5) Plaquemines +31 MTPA brownfield expansion filed with FERC/DOE (November 2025). (6) The Trump permitting tailwind (DOE non-FTA pause ended January 2025). (7) Capital-structure simplification in Q2-2026 (repaid the original Calcasieu construction loan; redeemed the $1.6B Stonepeak preferred). (8) A raised 2026 EBITDA guide to $8.2–8.5B — though this was Iran-war/commodity-price-driven, not durable.

Weakening developments / headwinds. (1) The arbitration wave crystallized — most importantly the BP partial liability award (October 2025), the first tribunal finding that VG breached its duty to declare COD, with BP seeking $3.7–6.0B and the damages phase unscheduled (expected 2026–27). (2) The 2026–28 supply glut moved from forecast to onset, compressing the spreads VG monetizes. (3) CP2 cost inflation to $32.5–33.5B (~$1,160–1,200/tonne), erasing the low-cost-builder edge on new vintages. (4) The stock’s broken-IPO trajectory itself (−57% off the day-one high) and a record ~87%-of-float short interest (the most-shorted name in the US market per a June-2026 screen). (5) Bernstein initiated at Market Perform (June 2026) with a $14 price target — measured, not bullish.

The most important tension: every “strengthening” development deepens the same bet — more leverage, more in-construction capex, more spot dependence, an unresolved uncapped BP overhang, and a Plaquemines setup that mechanically repeats Calcasieu. Execution is genuinely strong (150+ Calcasieu contracted cargoes delivered without a miss post-COD; CP2 build speed; the refi), but strong execution of an aggressive, litigious, debt-funded strategy is not the same as a de-risking thesis.

Verdict: mixed — the changes strengthen the growth story and weaken the quality/risk profile in equal measure. The trajectory is “bigger and more leveraged,” not “safer.”


9. Risk Analysis (Risk Matrix)

# Risk Likelihood Impact Evidence basis
1 BP uncapped damages $3.7–6.0B (cap likely inapplicable) Med-High (liability already found) High 10-K Legal Proceedings; Oct-8-2025 partial award; hearing 2026–27
2 Three other Calcasieu arbitrations + cap-busting (~$1.5B/$0.4B/$2.0B claims) Medium Med-High 10-K; awards expected 2026
3 Plaquemines repeat litigation / reputational damage Medium Med-High Commissioning since Jan-2025, no COD; Calcasieu precedent
4 2026–30 LNG supply glut compresses spot + future SPA fees High High IEA ~15% surplus by 2030; Qatar +49 MTPA; VG most spot-exposed
5 CP2/CP3 cost or schedule overrun ($32.5–33.5B, +tariffs) Medium High 10-K; COD delay can trigger project-finance events of default
6 Refinancing / interest-rate (floating construction debt; 8–10% HoldCo coupons) Medium High $37B debt, ~5.6x net-debt/EBITDA; nearest wall (Calcasieu) since repaid
7 Customer concentration (top 3 ~50% of revenue) Medium Med-High 10-K Note 4 (A 23% / B 14% / C 13%)
8 Commodity / Henry-Hub / TTF–JKM spread High High (near-term) Factor-model OilPrice beta ~2.8; ~$1/MMBtu ≈ ±$300–625M EBITDA
9 Founder super-voting governance (97.5% vote; comp lacks ROIC) High (structural) Medium DEF 14A; partial mitigant: founders are net buyers
10 Key-person dependence (Sabel; founder-driven design/IP) Low-Med Med-High Concentrated decision-making
11 Regulatory / permitting reversal (post-current-administration) Low-Med (favorable now) Med-High DOE/FERC tailwinds are reversible
12 ~87% short interest → squeeze (two-sided risk) High Medium Benzinga screen, Jun-11-2026
13 Equity-near-wipe in a bear case (thin residual behind ~$38.5B debt+minority+tail) Low-Med Catastrophic Valuation (bear ≈ $0)

The three swing risks all crystallize in 2026–27: the BP damages award (legal), the Plaquemines COD timing / repeat (reputational), and the supply glut (economic). Management’s framing on all three is materially more optimistic than its own filed 10-K language. There is no catastrophic operational loss risk akin to a single-asset blowup, but the financial catastrophic case is real: the equity is a thin, levered residual, and a billions-scale uncapped BP award stacked on glut-compressed economics could impair it severely.


10. Valuation Discussion (Embedded Expectations)

No price target, no recommendation — embedded expectations, comps, and scenarios only.

Clean EV at $10.95. Market cap = 2,482.6M shares × $10.95 ≈ $27.2B; + net debt ~$34.98B + minority ~$3.48B ≈ EV ~$65.6B. (Ignore ROIC’s headline ~$78B EV, which uses a higher quarter-end price; this matches ROIC’s average-quarter EV.)

The multiple stack — and why “cheap” is an illusion.

Metric VG (TTM) Read
EV/EBITDA ~10.6x EBITDA $6.2B is commissioning-spot inflated
EV/EBITDA (norm) ~13x On ~$5B contracted EBITDA for Calcasieu+Plaquemines — the real read
EV/sales ~4.2x Revenue spot-inflated
P/B 3.26x BV/share ~$3.36 — the cleaner anchor
P/S 1.87x 11th percentile of (short) own-history
P/E ~10.8x EPS $1.01 commissioning- and mark-distorted — discard

The own-history valuation-percentile data reads “cheap” — composite 15.8th percentile, P/E 21st, P/B 15th, P/S 11th — but the history is only ~17 months and the P/E percentile is built on distorted EPS. The cleaner signal is that VG trades at a discount to Cheniere on headline EV/EBITDA (10.6x vs ~15.1x) only because its EBITDA is spot-inflated and the market is appropriately discounting ~5.6x reported (higher normalized) leverage, 8–10% junk coupons, the BP/arbitration tail, and CP2/CP3 execution. The discount is a rational risk discount, not a bargain.

Comp set.

Comp EV EV/EBITDA Note
Cheniere (LNG) ~$91.4B ~15.1x The benchmark — built, IG, fully-contracted tolling, no litigation tail; premium deserved
NextDecade (NEXT) ~$13.7B n.m. (EBITDA negative) A pure pre-COD developer — VG’s DNA, one stage earlier
New Fortress (NFE) ~$8.8B n.m. (negative) Levered LNG gone wrong (debt/EV ~0.98) — a leverage-tail cautionary tale
Sempra (SRE) ~$109.6B ~19.0x Rate-base utility; only Sempra Infrastructure is a true LNG comp

Embedded-expectations / reverse read. To justify ~$65.6B EV at a ~12x contracted multiple, the market needs ~$5.5B of sustainable contracted EBITDA — which Calcasieu + Plaquemines alone roughly cover at steady state. So at $10.95 the equity is essentially pricing those two trains completing and performing, with CP2/CP3 as optionality not fully paid for. What must be true for that to hold: (a) Plaquemines reaches COD without a Calcasieu-style litigation blow-up; (b) CP2 ($32.5–33.5B) completes on time and budget; © the ~$2.50–3.00 fixed liquefaction fee survives the 2026–28 glut (take-or-pay protects existing SPAs, but new-SPA pricing and spot upside compress); and (d) BP lands near VG’s $595M cap rather than the $3.7–6.0B uncapped claim.

Scenario analysis (steady-state contracted EBITDA × EV/EBITDA − net debt − minority − litigation; 2,482.6M shares; deliberately wide — most value is in trains not yet operating):

Case Contracted EBITDA assumption Mult Implied EV Less debt/minority/litigation Equity/share (approx)
Bear ~$4.0B (fee ~$2.0–2.25, CP2 stalls, glut bites) 9x ~$36B −$32B / −$3.5B / −$5B (BP) ~$0 (near-equity-wipe)
Base ~$9.0B (Calc+Plaq+CP2, fee ~$2.75) 11x ~$99B −$42B / −$3.5B / −$2B ~$18–22
Bull ~$11.5B (+CP3, fee ~$3.0, modest re-rate) 13x ~$149B −$50B / −$4B / −$1B ~$35–40

The bear (~$0) / base (~$18–22) / bull (~$35–40) spread is enormous because the equity is a thin, levered residual behind ~$35B net debt, ~$3.5B minority, and a $3.7–6.0B BP tail. A modest change in the contracted EBITDA assumption or the litigation outcome swings the residual disproportionately. This is a levered option on completion, not a stable cash-flow stock.

SOTP / NAV sketch (cross-check). Calcasieu (operating, ~$1.3B EBITDA × ~12x − ~$5B VGCP debt ≈ ~$11B equity); Plaquemines (commissioning→COD, ~$3.5B EBITDA × ~11–12x − ~$18–20B VGPL debt, litigation-haircut ≈ ~$20–24B equity); CP2 (in-construction option ≈ ~$3–8B); CP3/Delta/expansion (pre-FID ≈ ~$0–5B). Gross ~$34–48B, less HoldCo notes (~$11B), the $3.0B Series A preferred, and the BP tail → residual common equity ~$20–30B in the base (~$8–12/share, very wide). The NAV confirms the scenario math: the equity is a thin residual highly sensitive to completion and litigation.

Bottom line on valuation: not cheap on normalized economics, fairly-to-modestly-priced as a probability-weighted completion option, with a fat left tail. The market is underwriting Calcasieu + Plaquemines; you are paying little for CP2/CP3 but taking the full leverage and litigation risk to get them.


11. Variant Perception

Consensus belief. Sell-side is cautious-neutral (Bernstein Market Perform, $14 PT, June-2026); the equity market treats VG as a high-beta, levered commodity bet — the factor model loads it on OilPrice (~+2.8) and CreditRisk (~+0.7) with zero style-factor signature, and clusters it with E&P names (GTE, VTS, BTE), with Cheniere — the only true LNG comp — absent from its peer set. The ~87%-of-float short interest says a large cohort is positioned for the bear case (glut + litigation + leverage). The tape is pricing a falling-knife-that-bounced, not a contracted-infrastructure annuity.

Strongest bull case. VG is the best builder in LNG, with a vast, largely-contracted volume pipeline (Calcasieu + Plaquemines + CP2 + CP3 + Delta + expansion) arriving into structurally rising long-term demand and a maximally-favorable permitting regime. The trailing leverage and litigation are transitional; as projects reach COD, contracted EBITDA scales toward $9–11B+, the company de-levers, achieves investment grade, and the equity re-rates toward Cheniere. The founders are buying. The 87% short is fuel for a squeeze. Base/bull equity of ~$18–40 is double-to-quadruple the current price.

Strongest bear case. The trailing earnings are a non-repeatable commissioning windfall; normalized EBITDA is ~$5B for the two near-done trains, on which the stock is ~13x — not cheap. The company is at war with the majors who fund LNG, carries a potentially-uncapped $3.7–6.0B BP award, and is the most glut-exposed US name just as ~200 MTPA of new supply compresses the spreads it monetizes. The equity is a thin residual behind ~$38.5B of debt + minority + litigation; a billions-scale BP award stacked on glut-compressed fees impairs it severely (bear ≈ $0). The low-cost-builder moat has already evaporated on CP2.

The 3–5 assumptions that matter most. (1) Plaquemines COD on schedule and without a new arbitration — the single most important near-term swing. (2) The BP damages outcome — cap ($595M) vs. uncapped ($3.7–6.0B). (3) CP2/CP3 on-time, on-budget completion at returns that justify the capex. (4) SPA-fee durability through the 2026–28 glut. (5) Continued access to junk-rated project finance at coupons the contracted economics can service.

What would falsify each side. Bull falsified by: a Plaquemines COD slip that triggers a second customer arbitration, or a multi-billion uncapped BP award. Bear falsified by: Plaquemines reaching COD cleanly and converting to contracted, BP settling near the cap, and CP2 first-LNG on schedule — which together would convert option value into annuity value and likely re-rate the equity.

The variant-perception punchline (from the factor read): the market prices VG as a 77%-vol oil-price-and-credit commodity instrument; the bull thesis requires it to become a stable contracted-infrastructure annuity. That mismatch — between what the tape treats it as and what it would be if everything gets built — is the variant perception. Which side is right is determined by execution and litigation outcomes that land in 2026–27, not by the current multiple.


12. Fact vs. Interpretation Table

# Statement Fact / Interpretation Basis / caveat
1 Calcasieu produced first LNG Jan-2022 but declared COD only April-2025 (~3 yrs late) Fact 10-K FY2025 Legal Proceedings / Note 4
2 VG sold commissioning cargoes at spot into the 2022–23 spike instead of delivering to SPAs Fact 10-K; arbitration record
3 The delay caused the windfall and the lawsuits — same act Interpretation Strongly supported but a characterization
4 BP won the liability phase (Oct-2025); seeks $3.7–6.0B; $595M cap likely inapplicable to BP Fact 10-K FY2025 (explicit on the cap)
5 TTM EBITDA ~$6.2B overstates the contracted steady state Interpretation Inferred from 56%→34% GM slide + spot mix
6 Normalized EV/EBITDA ~13x (vs ~10.6x headline) Interpretation Depends on ~$5B normalized-EBITDA estimate
7 Net debt ~$35B; HoldCo coupons 8–10%; net-debt/EBITDA ~5.6x Fact 10-K; ROIC
8 Founders are net open-market buyers; officers are exercise-and-sell Fact Form 4 filings
9 Founders control ~97.5% of votes via Class B Fact DEF 14A 2026
10 Comp has no ROIC/return/per-share metric Fact DEF 14A 2026
11 The low-cost-builder edge has evaporated on CP2 (~$1,160–1,200/tonne) Interpretation 10-K cost guide vs. legacy $/tonne
12 The 2026–28 supply glut will compress spreads and future SPA fees Interpretation IEA/Rystad supply-demand; directionally well-supported
13 Equity is a thin residual; bear case ≈ near-wipe Interpretation Scenario math on a levered residual
14 ~87% of float is short Fact (as reported) Benzinga screen Jun-2026 — verify vs. exchange short data

13. Open Questions

  1. BP damages quantum and timing. When does the damages phase conclude, and does the award land near the $595M cap or in the billions uncapped? This single outcome can swing the equity by multiples.
  2. Plaquemines COD. Does it hit the Q4-2026/mid-2027 guide, and — critically — do foundation SPA customers object to the commissioning duration the way Calcasieu’s did? Has any Plaquemines customer already filed or threatened?
  3. The three pending Calcasieu arbitrations (~$1.5B, ~$0.4B, ~$2.0B claims, awards expected 2026) — do the liability caps hold, and how do the tribunals read the same COD-delay facts that split Shell/Repsol (wins) from BP (loss)?
  4. Normalized per-train economics. What is the actual fixed-fee EBITDA per MTPA once Plaquemines is fully contracted and depreciating — i.e., is the ~$5B “two-train” estimate right?
  5. CP2 returns. Does CP2 actually earn the claimed >30% project ROIC at $32.5–33.5B of cost and competitively-set SPA fees, or is that a milestone-bonus-driven aspiration?
  6. Glut path. How fast does the TTF–HH spread compress, and where does new-SPA pricing settle as Qatar/US capacity floods 2027–28?
  7. Financing access. Can VG keep terming out construction debt at coupons its contracted economics can service if its credit reputation with majors is impaired?
  8. The $181–280M employee stock-option litigation — minor relative to BP, but another governance/HR flag worth tracking.

14. What Must Be True

Bull case — what must be true, and its falsification test.

  • Plaquemines reaches COD on schedule and converts cleanly to contracted volumes; CP2 and CP3 complete on time and on budget at returns that justify the capex; contracted EBITDA scales toward $9–11B+; VG de-levers toward investment grade; and the BP/arbitration tail resolves near the caps.
  • Falsification test: a Plaquemines COD slip that triggers a second customer arbitration, or a multi-billion-dollar uncapped BP damages award, or a CP2 cost/schedule blow-up that strands capital — any one of which breaks the de-leveraging-to-IG path on which the bull case depends. Watch the next two earnings prints for COD reaffirmation and the BP damages-phase calendar.

Bear case — what must be true, and its falsification test.

  • The commissioning windfall is non-repeatable; normalized two-train EBITDA is ~$5B, making the stock ~13x and not cheap; the glut compresses spot and future SPA fees; the BP award lands in the billions; and the thin levered equity is impaired toward the bear scenario.
  • Falsification test: Plaquemines reaches COD without a new dispute, BP settles near the $595M cap, and CP2 hits first-LNG on schedule — together converting option value into annuity value and likely re-rating the equity toward the base/bull zone. A clean Plaquemines COD print plus a capped BP settlement would be the bear-breaking evidence.

The symmetry is the point: the same 2026–27 catalysts (Plaquemines COD, BP damages, CP2 progress) resolve both cases. This is an event-driven, binary-tilted situation, not a slow fundamental compounding story.


15. Source Appendix

See the separate Source Appendix (Appendix B in the combined report) for the full, dated source list. Primary sources relied upon include: VG Form 10-K for FY2025 (filed 2026-03-02) — Legal Proceedings, Note 4 (revenue/SPAs/contingencies), risk factors; VG Form 10-K for FY2024 (filed 2025-03-06); Forms 10-Q for Q1–Q3 2025 and Q1 2026; DEF 14A proxy (2026); the Form 4 / Form 144 corpus since the January-2025 IPO; the 8-K material-event flood (arbitration awards, FID announcements, SPA signings, financings); VG earnings-call transcripts for 2025-Q4 and 2026-Q1; aggregated fundamentals/ratios and enterprise-value data; market price history and valuation-percentile data; factor-model data; and public industry data (EIA, IEA, Rystad, Argus) and trade/financial press (Bernstein initiation, Benzinga short-interest screen). Management commentary from transcripts is treated as hypothesis and flagged where it conflicts with the filed 10-K (notably on the BP cap and the supply glut).


APPENDIX A — Standard Diligence Questionnaire

Venture Global, Inc. (NYSE: VG) — Standard Diligence Questionnaire Appendix

Supplemental to the research memo. Report date 2026-06-27. Fact / Interpretation / Assumption labels applied where material. Where a question does not map to an LNG-developer model, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? The dominant questions are: (1) Is the trailing EBITDA a real run-rate or a commissioning-cargo windfall? (2) Will Plaquemines repeat the Calcasieu commissioning-delay litigation? (3) What is the realistic BP damages exposure — capped at $595M or uncapped at $3.7–6.0B? (4) Can a junk-rated developer with ~$35B net debt fund CP2/CP3 through a supply glut? (5) Is the ~87%-of-float short interest a value tell or a squeeze setup? (6) Does ~97.5% founder voting control make minority equity un-ownable on governance grounds? These map directly to the Financial Quality, Competitive Position, Risk, Capital Allocation, and Variant Perception sections.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? [Interpretation] At a structural/commissioning high. Reported margins are flattered by spot commissioning cargoes (gross margin fell 55.9%→34.0% across five quarters) and favorable gas marks; normalized contracted economics are lower. The 2026 EBITDA guide raise ($8.2–8.5B) was Iran-war/commodity-driven, not durable.

Driven by the external environment or internal actions? Both — internal (the decision to extend commissioning and sell spot) interacting with external (the 2022–23 and 2025–26 price spikes). The windfall is a deliberate strategy meeting a favorable tape.

How stable are revenues? Post-COD SPA revenue is contracted and stable (20-year take-or-pay, ~96% of the executed 47–52 MTPA book, ~$299.5B remaining performance obligation). But current revenue carries a large unstable spot-commissioning and excess-capacity component that normalizes away.

Outlook for products/services? LNG demand grows long-term (Shell: ~422→650–710 MTPA by 2040); VG’s contracted volume more than doubles if Calcasieu+Plaquemines+CP2 complete. The near-term (2026–28) outlook is dominated by the supply glut compressing spot and new-contract pricing.

How big is this market — growing, shrinking, domestic or international? Global, growing structurally but oversupplied near-term. US export capacity ~doubles by 2030–31; global liquefaction +~40% to ~740 MTPA by 2030. International demand (Europe, Asia), domestic feed-gas (Henry Hub).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More — ~200 MTPA of new global supply (largest wave ever), US ~60% of FIDs since 2019, Qatar +49–65 MTPA. Marathon late-cycle overbuild.

How profitable is the business (ROIC, ROE)? [Fact, distorted] ROIC 4.7% (2024) / 10.3% (2025); ROE optically high (61–540% historically) but meaningless on a thin, commissioning-distorted equity base with huge in-construction CWIP. Normalized ROIC is unproven — the asset base is too young. The correct analog is per-project return on the fixed liquefaction fee vs. ~$1.1–1.2B/MTPA capex; management claims >30% CP2 ROIC, unverified.

How profitable is the industry — competitors, barriers to entry? Capital-intensive (high barrier: ~$20–33B/project, FERC/DOE permits, multi-year build). Profitability is bifurcated: fully-contracted incumbents (Cheniere) earn stable tolling spreads; spot-exposed developers earn volatile, glut-sensitive margins.

Can the business be easily understood? Moderately. The two-engine (commissioning-spot vs. contracted-SPA) model and the project-level non-recourse capital structure require work to disentangle; the trailing financials are misleading without normalization.

Can it be undermined by foreign low-cost labor? Not labor — but by foreign low-cost capacity: Qatar’s North Field is the lowest-cost LNG in the world and is expanding aggressively, capping global pricing.

Do brands matter? No consumer brand. Counterparty reputation matters enormously — and VG’s is impaired (it is in arbitration with the majors who fund LNG). This is a moat-negative, the inverse of a brand.

Nature of competition? Competition for offtake SPAs and for low-cost capital, on a globally-priced commodity. VG is a price-taker.

Customers’ switching costs? Once a 20-year SPA is signed, switching is contractually costly (take-or-pay) — but that locks in existing customers; it does nothing to win new ones, where VG’s reputation is the headwind.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The contracted backlog (~$299.5B RPO) is an economic asset not on the balance sheet. Conversely, gross PP&E ($52.5B) is barely depreciated (accum. deprec. $1.99B) — a forward GAAP-margin liability as depreciation ramps.

Off-balance-sheet liabilities? The arbitration exposure is the key contingent liability — BP $3.7–6.0B (potentially uncapped) plus three pending claims (~$1.5B/$0.4B/$2.0B) and an employee option suit ($181–280M). VG accrues only a ~$13M/quarter non-cash revenue reserve, small relative to the claimed quanta. [Fact]

How conservative is the accounting? [Interpretation] Aggressive-to-fair. Net income is distorted by large non-operating fair-value marks on forward gas contracts (e.g., −$704M Q4’24, +$415M Q1’26); the small litigation accrual is optimistic relative to the BP claim. Treat NI/EPS as low-quality.

How CapEx-hungry is the business? Extremely — ~$13B/year, negative FCF every year (−$11.6B 2024, −$6.8B 2025), positive FCF not expected until ~2028+.

Capital Allocation & Management

How much FCF, and how is it used? Currently negative. Steady-state FCF (post-build) would fund debt service first, then de-leveraging, then (eventually) capital returns. Management is explicit: reinvest everything until CP2 cash flows materialize.

Significant acquisitions recently? No major M&A — growth is organic greenfield/brownfield development (Calcasieu→Plaquemines→CP2→CP3→Delta→+31 MTPA expansion).

Buying back shares? No common buyback (token ~$0.03/share 2025 dividend; the $465M “dividends” are mostly the $3.0B 9.5% Series A preferred). Capital returns to common are symbolic by design.

Issuing large amounts of stock to insiders? SBC modest (~$46M FY25). Officers hold low-strike (~$0.79) options being exercised-and-sold. Founders hold ~79% economics via super-voting Class B and are net buyers in the open market. [Fact]

Compensation policy of directors/management? [Fact — moat-negative] Anchored on project-milestone bonuses (FID/first-cargo/COD) and EBITDA growth, with no ROIC, return-on-capital, or per-share metric. CEO Sabel 2025 comp ~$39.1M. Rewards throughput/FID velocity — the over-build the capital-cycle lens flags.

Motivations of management? Founder-led, control-entrenched (~97.5% vote), growth-maximizing. Aligned by ownership/open-market buying; misaligned by incentive design and the absence of a minority-governance check.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a US C-corporation, NYSE-listed common (Class A). No K-1. Multi-class (A public; B founder super-voting; C/D). [Fact]

Dividend policy? Token common dividend (~$0.03/share 2025); no meaningful yield. Capital returns deferred until CP2 cash flows. A $3.0B 9.5% perpetual preferred sits above common.

How profitable is the business? See Financial Quality — high reported margins that overstate the contracted steady state.

Is net income diverging from cash from operations? Yes, materially — NI is mark-distorted; OCF ($6.57B 2025) is large but dwarfed by ~$13B capex, so FCF is deeply negative. Anchor on normalized contracted economics, not NI or OCF.

Risks & Downside

What would cause the stock to decline? A multi-billion uncapped BP award; a Plaquemines COD slip and/or a new customer arbitration; CP2 cost/schedule overrun; faster glut-driven spread compression; a financing-cost spike; a short-driven or fundamental de-rating. (See the Risk matrix.)

Risk of catastrophic loss? [Interpretation] Yes, financially — the equity is a thin, levered residual behind ~$38.5B of debt + minority + litigation; the bear scenario approximates a near-equity-wipe. There is no single-asset operational catastrophe risk comparable to the financial tail.

Chance of a total loss? Low-to-moderate but non-trivial — it would require the bear case (uncapped BP + glut-compressed economics + a financing/completion failure) to compound. Not a base case, but a real left tail that argues against position-sizing this as a normal equity.

Recent News & Events

Has the business environment changed recently? Yes — (1) the BP liability loss (Oct-2025) crystallized the litigation tail; (2) the supply glut moved from forecast to onset; (3) CP2 cost inflated to ~$33B; (4) Plaquemines commissioning began the same spot-windfall pattern as Calcasieu; (5) the Iran-war/Hormuz energy spike (Jun-2026) temporarily lifted then reversed the stock; (6) Bernstein initiated Market Perform ($14 PT); (7) ~87%-of-float short interest reported.

Significant acquisitions? None material (organic developer).

Change in accounting policies? None flagged; watch the depreciation ramp and the gas-contract fair-value marks.

Recent changes — new markets, facilities, management? New SPAs (Naturgy, Hanwha/first-South-Korea, EnBW, ExxonMobil/Atlantic-SEE, Vitol, TotalEnergies); CP2 FID and financing; Plaquemines +31 MTPA expansion filed; Q2-2026 capital-structure simplification (repaid Calcasieu construction loan, redeemed Stonepeak preferred). Founder-led management stable; no major leadership change.


APPENDIX B — Source Appendix

Venture Global, Inc. (NYSE: VG) — Source Appendix

Report date 2026-06-27. Primary sources first. All financial figures reconciled to SEC filings where possible; third-party data providers used for ratios/prices and cross-checked to filings.

Primary — SEC Filings (EDGAR, CIK 0002007855)

Source Form Date Use
Venture Global, Inc. Form 10-K (FY2025) 10-K 2026-03-02 Legal Proceedings (arbitration scorecard, BP cap), Note 4 (revenue, SPAs, RPO $299.5B, customer concentration), risk factors, debt schedule, PP&E
Venture Global, Inc. Form 10-K (FY2024) 10-K 2025-03-06 First annual report; commissioning model; FY2024 financials
Form 10-Q Q1 2025 10-Q 2025-05-13 Quarterly financials, Calcasieu COD (Apr-2025)
Form 10-Q Q2 2025 10-Q 2025-08-12 Quarterly financials
Form 10-Q Q3 2025 10-Q 2025-11-10 Quarterly financials; arbitration updates
Form 10-Q Q1 2026 10-Q 2026-05-12 Latest quarterly; margin compression (GM 34.0%); debt $37.3B
DEF 14A (proxy) DEF 14A 2026 Executive comp (milestone bonuses, no ROIC metric), Sabel ~$39.1M, multi-class voting (~97.5% founder control)
Form 4 / Form 144 filings 4 / 144 2025–2026 Insider activity — founder open-market buys (code P); officer exercise-and-sell (code M→S, ~$0.79 strike)
8-K material-event corpus (32 filings) 8-K 2025–2026 BP/Shell/Repsol/Edison arbitration awards; CP2 FID & $15.1B/$8.6B financings; SPA signings; HoldCo/project debt issues; Stonepeak preferred redemption
S-1 / S-1/A S-1/A 2024–2025 IPO prospectus; pre-IPO financials; project descriptions
Form 8-A12B 8-A12B 2025-01-23 Securities registration / IPO

Primary — Earnings Call Transcripts

Call Date Use
VG Q4 2025 earnings call 2026-03-02 Plaquemines COD guidance (Q4-2026/mid-2027), CP2 cost/ROIC claims, arbitration framing, glut dismissal
VG Q1 2026 earnings call 2026-05-12 Latest management framing; capital-structure simplification; SPA pipeline; 2026 EBITDA guide
VG Q3 2025 / Q1 2025 calls 2025-11-10 / 2025-05-13 Earlier guidance and arbitration commentary

(Note: pre-2025 “VG” earnings calls in third-party databases are the former Vonage ticker and were excluded.)

Quantitative Data Tools (third-party; reconciled to filings)

Tool Use
Aggregated fundamentals provider Income statement, balance sheet, cash flow (multi-period); profitability/credit/valuation ratios; enterprise value ($65.6B avg-quarter); comp pulls (LNG, NEXT, NFE, SRE)
Market price-history data Daily OHLCV, adjusted/unadjusted, EMAs, beta — five-year event map; all-time high $25.50 (2025-01-24), low $5.72 (2025-12-16)
Valuation-percentile data Own-history percentiles — composite 15.8th, P/E 21st, P/B 15th, P/S 11th (caveat: ~17-month history; EPS distorted)
News aggregation Recent-events timeline; Bernstein initiation; ~87% short interest; Iran-war/Hormuz energy moves
Factor-model provider Factor loadings (OilPrice ~+2.8, CreditRisk ~+0.7, no style signature), leaderboard (y1 −34%, 77% vol), related-stocks (E&P cluster; Cheniere absent)
SEC EDGAR Filing enumeration; XBRL concept pulls

Secondary — Industry & Financial Press

Source Use
EIA (US LNG export capacity / volumes, 2026) US ~102 MTPA, doubling by 2030–31; Golden Pass first LNG Mar-2026
IEA (Global LNG outlook, 2025–26) ~15% capacity surplus by 2030; ~740 MTPA global liquefaction
Rystad Energy (LNG supply-demand, 2025–26) +193 MTPA supply vs. +144 MTPA Asian demand 2025–30
Argus / trade press (LNG pricing, 2025–26) TTF–HH spread compression; $3 fee contracts vs delivered NW-Europe prices by 2027
Shell LNG Outlook (2026) Global LNG demand ~422→650–710 MTPA by 2040
Bernstein (initiation, 2026-06-17) Market Perform, $14 price target
Benzinga (short-interest screen, 2026-06-11) VG ~87% of float short — most-shorted US name

Methodology Notes

  • Normalization: Trailing EBITDA/EPS are treated as commissioning-spot-inflated; valuation anchored on an estimated normalized contracted EBITDA (~$5B for Calcasieu+Plaquemines) and project NAV, not on headline multiples.
  • Litigation figures (BP $3.7–6.0B; $595M cap; Shell/Repsol wins; Edison settlement) are taken from the FY2025 10-K Legal Proceedings as the primary source, superseding press estimates where they differ.
  • Management commentary from transcripts is treated as hypothesis and flagged where it conflicts with the filed 10-K (notably the BP cap applicability and the supply-glut outlook).
  • Ownership: No position is implied or assumed; VG is analyzed position-agnostically.